Alirocumab (Mai Martaba)

Wadatacce

• Nunin Alirocumab (Maɗaukaki)
• Nasihu don amfani da Alirocumab (Praluent)
• Sakamakon sakamako na Alirocumab (Praluent)
• Rauntatawa ga Alirocumab (Praluent)
• Inda zan sayi Alirocumab (Praluent)

Alirocumab magani ne wanda ke rage cholesterol kuma, saboda haka, rage haɗarin cututtukan zuciya da zuciya kamar su bugun zuciya ko bugun jini, misali.

Alirocumab magani ne na allura mai sauƙin amfani don amfani dashi a cikin gida, wanda ya ƙunshi anti-body wanda zai iya hana aikin PSCK9, enzyme wanda ke hana a kawar da mummunan cholesterol daga jini.

Nunin Alirocumab (Maɗaukaki)

Ana nuna Alirocumab don shari'ar marasa lafiya tare da babban cholesterol na asalin gado ko kuma waɗanda cholesterol ba ya raguwa sosai tare da amfani da magunguna na yau da kullun, kamar su Simvastatin har ma a iyakar gwargwadon izininsa.

Nasihu don amfani da Alirocumab (Praluent)

A yadda aka saba 1 allurai 75mg ake nunawa duk kwana 15, amma likita na iya kara adadin zuwa 150mg duk bayan kwana 15 idan ya zama dole a rage matakan cholesterol da fiye da 60%. Za a iya amfani da allurar ta hanyar kai tsaye a cinya, ciki ko hannu, yana da mahimmanci a sauya shafukan aikin.

Mutumin ko mai kula dashi zasu iya yin allurar bayan bayanin likita, nas ko likitan magani amma abu ne mai sauƙi a yi amfani dashi saboda ya ƙunshi alkalami da aka riga aka cika don amfani ɗaya.

Sakamakon sakamako na Alirocumab (Praluent)

Matsalar rashin lafiyan kamar ƙaiƙayi, eclam nummular da vasculitis na iya bayyana kuma yankin allurar na iya kumbura da ciwo. Bugu da kari, abu ne na yau da kullun don bayyanar cututtuka a cikin tsarin numfashi kamar atishawa da rhinitis.

Rauntatawa ga Alirocumab (Praluent)

Wannan magani ba a nuna shi ba ga yara da matasa har zuwa shekaru 18, da mata masu ciki saboda ba a gudanar da gwajin lafiya a cikin waɗannan halayen ba. Haka kuma ana hana shi yayin shayarwa saboda yana wucewa ta madarar nono,

Inda zan sayi Alirocumab (Praluent)

Alirocumab magani ne mai sunan kasuwanci na Praluent, wanda dakunan gwaje-gwajen Sanofi da Regeneron ke gwada shi, kuma har yanzu bai samu damar siyarwa ga jama'a ba.

A yadda aka saba, magungunan cholesterol na al'ada, kamar su simvastatin, suna haɓaka samar da PSCK9 kuma, sabili da haka, bayan ɗan lokaci, maganin ba shi da inganci sosai wajen rage ƙwayar cholesterol. Don haka, ana iya amfani da Alirocumab don haɗawa da magani tare da wannan nau'in magani, ban da kasancewa ana iya amfani da shi azaman magani ɗaya a cikin marasa lafiyar da basu iya rage ƙwayar cholesterol tare da magunguna na al'ada.

Bincika yadda za'a dace da magani don sarrafa cholesterol na jini:

• Maganin Cholesterol
• Abincin rage cholesterol